It is estimated that less than one in ten people with dementia are eligible for treatment with Lecanemab or Leqembi, the ...

AI-driven MRI solution, icobrain aria receives US FDA clearance for safer Alzheimer’s treatment: Boston Saturday, November 16, 2024, 16:00 Hrs [IST] icometrix, a g ...

EMA committee recommends approval of Eisai & Biogen’s lecanemab to treat early Alzheimer’s disease: Tokyo Saturday, November 16, 2024, 13:00 Hrs [IST] Eisai Co., Ltd. and Biog ...

A new exhibition at Glasgow Royal Infirmary is shedding light on the city's last outbreak of smallpox, in 1950, and its parallels with Covid.

GOV.UK states that the Medicines and Healthcare products Regulatory Agency (MHRA) "approved a product licence for the ...

Lecanemab is the first treatment for Alzheimer’s disease licensed for use in Great Britain that shows some evidence of ...

A groundbreaking medication designed to delay the onset of Alzheimer's has received approval for use within the EU. The drug, ...